Navigation Links
Lloyd Wright's Alternative Medicine Marketing Only Blueberry Extract with 45% of Hepatitis C Inhibitor Proanthocyanidin
Date:11/1/2009

Alternative Medicine is Currently Offering a Blueberry Extract with a compound that fights chronic liver disease Infections caused by Hepatitis C. Lloyd Wright survived Hepatitis and has in fact been deemed free from a malady that doctors claim is incurable. The Blueberry Extract has a compound derived from blueberry leaves and is very powerful, Lloyd's extract is the only one on the market with 45% Proanthocyanidin

Los Angeles (PRWEB) November 1, 2009 -- Lloyd Wright, author of Triumph Over Hepatitis C and President of Alternative Medicine, Inc., is currently marketing the only Blueberry Extract which contains 45% Proanthocyanidin, a powerful compound derived from blueberry leaves which has proved a potent inhibitor of Hepatitis C virus (HCV) infections. Wright, whose company offers a wide of variety of natural products to combat Hepatitis C, has a simple message for anyone taking other blueberry extracts: "If the blueberry extract you are taking does not say PROANTHOCYANIDIN on the label, it is not helping stop Hepatitis C. Our Blueberry extract is the only one the market today which contains 45% Proanthocyanidin."

The story of Lloyd Wright's Blueberry Extract is an interesting one. First, Hepatitis C virus (HCV) infection is a major cause of chronic liver disease such as chronic hepatitis, cirrhosis, and hepatocellular carcinoma. Then, while searching for new natural anti-HCV agents in agricultural products, we found a potent inhibitor of HCV RNA expression in extracts of blueberry leaves when examined in an HCV subgenomic replicon cell culture system.

This activity was observed in a methanol extract fraction of blueberry leaves and was purified by repeated fractionations in reversed-phase high-performance liquid chromatography. The final purified fraction showed a 63-fold increase in specific activity compared with the initial methanol extracts and was composed
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Lloydspharmacy Reveals Hayfever Misery to Hit One in Two People by 2060
2. Darwins Kim Lloyd to Speak on Panel at American Hospital Association Solutions Roundtable, June 3, 2009
3. Lloyd I. Miller III Announces Voting Intentions for United American Healthcares Annual Meeting
4. Ricky Tomlinson Joins Lloydspharmacy Against Coronary Heart Disease
5. InterCure Secures Nationwide Distribution Agreement With Lloyds Pharmacy Group
6. Delaware Hospice Honors President and CEO Susan D. Lloyd, MSN, RN
7. An Alternative To Adderall?
8. Survey Reveals Parents Are Eager to Learn about Alternative Medicine Options but Information is Lacking
9. The Obamacare Alternative: 33 State Think Tanks Announce Patient-Centered Health Care Reforms
10. California Surgeon (laserbacksurgery.com) Pioneers Exciting Alternative to Traditional Spinal Stenosis Treatment
11. SinusWars LLC Launches a Successful and All Natural Alternative to Antibiotics in the Fight to Treat Chronic Sinusitis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... Texas (PRWEB) May 06, 2015 ... of the HIMSS EMR Adoption Model, the hospital ... improve patient engagement and automate processes. The leadership ... from paper-driven to electronic workflows, patient registration still ... copies of consents. With HIMSS Stage 7 attestation ...
(Date:5/6/2015)... (PRWEB) May 06, 2015 Corporate ... behalf of MEBC, an Alliance Award for excellence ... during FOCUS 2015, JDA’s annual user conference which ... retail and wholesale distribution sectors. This award recognizes ... are receiving services that advance their supply chain ...
(Date:5/6/2015)... 06, 2015 The Beryl Institute announces ... of Patient Experience Journal (PXJ), an international, open access, ... understanding and improving patient experience. The second volume of ... conversation globally, helps align the voices engaged and provides ... Published in association with The Beryl Institute, Volume 2, ...
(Date:5/6/2015)... Marketing Maven announces a ... sanitation and hygiene nonprofit by GuideStar’s Philanthropedia. , “WaterAid ... and it brings our agency great joy to work ... “The ongoing relationship between WaterAid and Marketing ... learn about and support the nonprofit as they aim ...
(Date:5/6/2015)... 06, 2015 Wolters Kluwer , ... and students, announced today that in a survey of ... use of the clinical decision support resource improves the ... of 2014, UpToDate users in more than 170 countries ... month, on average. In Germany alone, 95% of all ...
Breaking Medicine News(10 mins):Health News:Access Electronic Patient Signatures Help Hilo Meet HIMSS Stage 7 Paperless Targets & Save $200,000 a Year on Consent Forms 2Health News:Access Electronic Patient Signatures Help Hilo Meet HIMSS Stage 7 Paperless Targets & Save $200,000 a Year on Consent Forms 3Health News:MEBC Receives Award for Consulting Excellence in Retail 2Health News:Patient Experience Journal Releases Spring 2015 Issue 2Health News:Marketing Maven Expands Partnership with the #1 Ranked International Water, Sanitation and Hygiene Nonprofit 2Health News:Marketing Maven Expands Partnership with the #1 Ranked International Water, Sanitation and Hygiene Nonprofit 3Health News:Current, Evidence-Based Knowledge for Physicians: UpToDate supports quick and accurate decision support for diagnosis and treatment 2Health News:Current, Evidence-Based Knowledge for Physicians: UpToDate supports quick and accurate decision support for diagnosis and treatment 3
... 500 Executive Driving Global Breast Cancer Leader,s Promise ... End Breast Cancer Forever, ATLANTA, Jan. 12 Hala ... the global leader in the fight to end breast,cancer forever, ... annual Trumpet Awards event in Atlanta with a ,High Heels ...
... Diseases than Ever ... ... childhood influenza and adolescent meningococcal,vaccinations are included in the 2008 Childhood ... Control and,Prevention (CDC), the American Academy of Pediatrics (AAP), and the,American ...
... NEW YORK, Jan. 11 The Substance Abuse ... from the National Survey on Drug Use and ... S. aged 12 to 25 have abused non-prescription,over-the- ... high at least once,in their lifetime. This announcement ...
... health care reform is too important, the stakes for, Californians ... ... changes., SACRAMENTO, Calif., Jan. 11 As the ... hammered out by Governor Arnold Schwarzenegger and Assembly,Speaker Fabian Nunez, the state,s ...
... genetic, biological causes could lead more to feel comfortable ... When people understand the genetics and biology of anorexia ... the eating disorder for their illness, says a University ... , "This is a potentially important finding because it ...
... diet and lifestyle are at root of reduced risk, , , FRIDAY, ... in your blood may reduce your risk of stroke, new research ... C in their blood had a 42 percent lower risk of ... which is in the January issue of The ...
Cached Medicine News:Health News:Susan G. Komen for the Cure's CEO Hala Moddelmog Earns 'High Heels in High Places' Recognition at 2008 Trumpet Awards 2Health News:Susan G. Komen for the Cure's CEO Hala Moddelmog Earns 'High Heels in High Places' Recognition at 2008 Trumpet Awards 3Health News:Health Groups Release 2008 Immunization Schedules 2Health News:Statement of Steve Pasierb, President and CEO, Partnership for a Drug-Free America on New SAMHSA Study On Cough Medicine Abuse 2Health News:Statement of Steve Pasierb, President and CEO, Partnership for a Drug-Free America on New SAMHSA Study On Cough Medicine Abuse 3Health News:Statement of Steve Pasierb, President and CEO, Partnership for a Drug-Free America on New SAMHSA Study On Cough Medicine Abuse 4Health News:Insurance Agents Call for State Senate to Improve California's Health Care Reform Compromise 2Health News:Science Could Erase Stigma of Anorexia 2Health News:Vitamin C May Play Role in Stroke Prevention 2Health News:Vitamin C May Play Role in Stroke Prevention 3
(Date:5/6/2015)... 2015  CTI BioPharma Corp. (NASDAQ and MTA: CTIC) ... March 31, 2015. "After reporting ... trial of pacritinib during the quarter, we have subsequently ... who are excited by the potential opportunity for pacritinib ... treatment of patients with myelofibrosis, specifically in the portion ...
(Date:5/6/2015)... May 6, 2015  Mirati Therapeutics, Inc. ("Mirati") (NASDAQ: ... first quarter ended March 31, 2015 and provided an ... "We continue to make progress across our targeted oncology ... Ph.D., president and CEO, Mirati. "We look forward to ... Society of Clinical Oncology meeting at the end of ...
(Date:5/6/2015)... -- Delcath Systems, Inc. (NASDAQ: DCTH ), a ... with an emphasis on the treatment of primary and ... months ended March 31, 2015.  Highlights ... , Achieved quarterly product revenue of $0.44 million, an ... quarter of 2014; , Activated a prospective patient ...
Breaking Medicine Technology:CTI BioPharma Reports First Quarter 2015 Financial Results 2CTI BioPharma Reports First Quarter 2015 Financial Results 3CTI BioPharma Reports First Quarter 2015 Financial Results 4CTI BioPharma Reports First Quarter 2015 Financial Results 5CTI BioPharma Reports First Quarter 2015 Financial Results 6CTI BioPharma Reports First Quarter 2015 Financial Results 7CTI BioPharma Reports First Quarter 2015 Financial Results 8CTI BioPharma Reports First Quarter 2015 Financial Results 9Mirati Therapeutics Reports First Quarter 2015 Financial Results and Provides Business Update 2Mirati Therapeutics Reports First Quarter 2015 Financial Results and Provides Business Update 3Mirati Therapeutics Reports First Quarter 2015 Financial Results and Provides Business Update 4Mirati Therapeutics Reports First Quarter 2015 Financial Results and Provides Business Update 5Delcath Reports 2015 First Quarter Financial Results 2Delcath Reports 2015 First Quarter Financial Results 3Delcath Reports 2015 First Quarter Financial Results 4Delcath Reports 2015 First Quarter Financial Results 5Delcath Reports 2015 First Quarter Financial Results 6Delcath Reports 2015 First Quarter Financial Results 7Delcath Reports 2015 First Quarter Financial Results 8
... Cardica, Inc. (Nasdaq: CRDC ) today ... marketing. In this role, Mr. Littel will be responsible ... Cardica,s existing cardiac surgery devices and its planned MicroCutter™ ... surgery. "Chris brings experience as a successful ...
... -- ShangPharma Corporation (NYSE: SHP ) ... and biotechnology research and development outsourcing company, today ... subsidiary, Shanghai ChemPartner Co. Ltd. ("ChemPartner"), acquired the ... River") Shanghai research facility. As ...
Cached Medicine Technology:Cardica Appoints Christopher Littel VP, Sales and Marketing 2Cardica Appoints Christopher Littel VP, Sales and Marketing 3ShangPharma Purchases Shanghai In-vivo Drug Research Facility from Charles River 2
... rod, and screw system designed to treat various ... utilizes a low profile design that incorporates anatomic ... The load sharing design of the 5.5 Titanium ... be applied when used with proper anterior column ...
BLF21A Alarm Model measures microcirculation in 1 cubic mm of tissue for real-time assessment of perfusion....
A portable, easy to use, dual-channel laser-Doppler tissue perfusion and temperature monitoring system, at a remarkably affordable price....
... featured laser doppler system for continuous ... multiple tissue sites. This latest generation ... Processing (DSP) and laser Doppler flowmetry ... to use, multi-channel monitor, setting new ...
Medicine Products: